Clinical Trial Recruitment Calls and Texts: TCPA Exposure for Sponsors

Most clinical trial recruitment calls and texts aren’t telemarketing under the Telephone Consumer Protection Act, because study volunteers aren’t asked to buy anything. The exposure sits elsewhere. Prerecorded and AI-voice calls to cell phones need consent whatever they say, the FCC’s healthcare exemption doesn’t list recruitment, and two federal appeals courts disagree about whether offering payment makes a message an advertisement. A sponsor or site facing one of these claims often has a strong defense built on what the message actually said.

Is a clinical trial recruitment call “telemarketing” under the TCPA?

Usually not, because 47 U.S.C. § 227(a)(4) defines a telephone solicitation by its aim of “encouraging the purchase or rental of, or investment in, property, goods, or services.” The FCC’s definition of telemarketing in 47 C.F.R. § 64.1200(f)(13) uses the same words. A text asking whether a patient with type 2 diabetes wants to be screened for a study doesn’t ask anyone to buy, rent, or invest in anything.

In its 2003 order, the FCC drew the same line for survey calls, saying calls outside the definition of telephone solicitation “may include surveys, market research, political or religious speech calls,” according to FCC 03-153. The same footnote warns that such calls can still be barred if they’re a pretext for an advertisement.

Paragraph 142 of that order is where recruitment campaigns get into trouble. It says a “dual purpose” call is an advertisement if the caller intends to sell something “either during the call, or in the future,” per FCC 03-153. The Ninth Circuit, whose decisions bind federal courts in California, relied on that order in Chesbro v. Best Buy Stores, writing that “Neither the statute nor the regulations require an explicit mention of a good, product, or service where the implication is clear from the context.”

A recruitment text stays informational under the 2003 order only while it sticks to the study. Add a line promoting the site’s paid weight-loss program or a sponsor’s already-approved drug, and the message starts to look like marketing. Companies outside healthcare face the same problem with account messages, and the analysis of when a payment reminder turns into telemarketing carries over almost directly.

Does paying study volunteers make the message an advertisement?

Paying volunteers might, because § 64.1200(f)(1) defines an advertisement as “any material advertising the commercial availability or quality of any property, goods, or services,” and the federal appeals courts have split over paid participation. Both leading cases involved faxes offering doctors money to take part in market research.

In Fischbein v. Olson Research Group (May 15, 2020), the Third Circuit held that “Any fax announcing the availability of an opportunity for the recipient to exchange goods or services for compensation is” an advertisement under the TCPA. The Second Circuit disagreed in Bruce Katz, M.D., P.C. v. Focus Forward, LLC (Jan. 6, 2022), holding that “a faxed invitation to participate in a market research survey in exchange for money does not constitute an” advertisement under the statute. Neither decision binds courts in California.

A recruitment text offering up to $1,200 for completing study visits looks a lot like the Fischbein faxes. The FDA’s guidance doesn’t help with the label. It says “FDA considers direct advertising for study subjects to be the start of the informed consent and subject selection process,” in Recruiting Study Subjects. That’s a regulatory label, not the TCPA’s definition, but plaintiffs’ lawyers will quote it anyway.

Under § 64.1200(a)(2), an advertisement needs a stronger form of consent. A prerecorded or autodialed call to a cell phone that “includes or introduces an advertisement or constitutes telemarketing” requires prior express written consent, meaning a signed agreement (electronic signatures count) that names the number and authorizes marketing calls. A purely informational call needs only ordinary consent. The paid-participation question has come up in other settings too, including job and staffing messages that offer paid work.

Sponsors shouldn’t volunteer to be the first test of Fischbein’s reasoning on phone calls. Until a court in the Ninth Circuit takes a side, the safer course is to get written consent for any automated recruitment message that mentions compensation. The FDA guidance already says ads “may state that subjects will be paid” without dwelling on the amount, so keeping dollar figures out of the first text costs very little.

Which consent rules apply to recruitment calls and texts?

The consent rule in § 227(b)(1)(A) applies to most recruitment campaigns whatever the message says. It bars calls to cell phones using an autodialer or an artificial or prerecorded voice unless the call is for emergency purposes or “made with the prior express consent of the called party.” A prerecorded message is a recording played instead of a live caller. An informational study invitation needs that consent just as a sales pitch does.

In Facebook, Inc. v. Duguid, the Supreme Court held that an autodialer must use a “random or sequential number generator,” and a platform that texts a list of patient numbers usually doesn’t. Voice is different. In February 2024 the FCC ruled that the TCPA’s voice restrictions cover “current AI technologies that generate human voices,” in FCC 24-17. An AI agent that calls patients to prescreen them needs consent the same way a recording does.

In a 2015 ruling, the FCC said giving a number to a healthcare provider is consent for HIPAA-covered healthcare calls made “within the scope of the consent given, and absent instructions to the contrary,” according to FCC 15-72, paragraph 141. Sites often assume a patient’s intake form covers recruitment, and that’s an open question. HIPAA defines health care as “care, services, or supplies related to the health of an individual” in 45 C.F.R. § 160.103, but it defines research separately, as an investigation “designed to develop or contribute to generalizable knowledge,” in 45 C.F.R. § 164.501. A sponsor-funded study call to a patient who gave the number for a knee replacement is a harder consent case than an appointment reminder.

Since June 2025, courts have given these FCC rulings less weight than they used to. The Supreme Court’s McLaughlin decision on FCC deference leaves a district court to decide the statute’s meaning itself while “affording appropriate respect to the agency’s interpretation,” in the words of McLaughlin Chiropractic Associates v. McKesson Corp. That cuts both ways for a sponsor relying on the 2015 consent ruling.

Does the FCC’s healthcare exemption cover trial recruitment?

Almost certainly not, because the free-to-end-user exemption in § 64.1200(a)(9)(iv) lists specific healthcare messages and recruitment isn’t one of them. The exemption lets healthcare providers make certain calls and texts to cell phones without consent, but only for “appointment and exam confirmations and reminders, wellness checkups, hospital pre-registration instructions, pre-operative instructions, lab results, post-discharge follow-up intended to prevent readmission, prescription notifications, and home healthcare instructions.” The same paragraph says those messages “must not include any telemarketing, solicitation, or advertising.”

In FCC 15-72, paragraph 146, the FCC limited the exemption to “calls for which there is exigency and that have a healthcare treatment purpose.” A study invitation rarely has that urgency. The exemption also carries conditions most recruitment programs don’t meet, including one message per day and no more than three per week to each patient.

A separate carve-out in § 64.1200(a)(2) excuses HIPAA “health care” messages from the written-consent requirement, but not from ordinary consent. The FCC confirmed in footnote 481 of FCC 15-72 that such calls to wireless numbers “are still covered by the general consent requirement.” Given HIPAA’s separate definition of research, a sponsor shouldn’t build a campaign on the theory that recruitment is a health care message.

Who answers for calls a site or recruitment vendor makes?

Under FCC 13-54, a seller “may be held vicariously liable under federal common law agency principles” for calls a third party makes, so a sponsor can be on the hook even when it never dialed a number. Multi-site trials often layer a sponsor, a contract research organization, a recruitment vendor, and dozens of sites, and the plaintiff will name whoever has money.

The indemnity and consent warranties in TCPA vendor contracts decide much of that fight. An agreement that assigns consent collection to the vendor and bars automated calls without consent records gives a sponsor a defense and a claim over. Those terms deserve a fresh look before a recruitment vendor launches a campaign.

The National Do Not Call Registry is the federal list of numbers whose owners don’t want telephone solicitations, and the private claim under § 227(c)(5) requires “more than one telephone call within any 12-month period” from the same entity. A pure study invitation isn’t a telephone solicitation. A program that mixes recruitment with paid services is one, and the company running it should already have Registry access as a seller under its own account.

Claims and defenses in a recruitment campaign

Claim theory Where it comes from Exposure per call or text Defenses that answer it
Prerecorded or AI-voice call to a cell phone 47 U.S.C. § 227(b)(1)(A)(iii), (b)(3) $500, or up to $1,500 if willful or knowing Prior express consent, scope of the patient’s consent, FCC 15-72 paragraph 141
Same call, alleged to be an advertisement 47 C.F.R. § 64.1200(a)(2) $500, or up to $1,500 if willful or knowing Katz reasoning, no compensation or product pitch in the script, signed written consent
Autodialed recruitment texts 47 U.S.C. § 227(b)(1)(A) $500, or up to $1,500 if willful or knowing Duguid’s random-or-sequential definition, prior express consent
Calls or texts to Registry numbers 47 C.F.R. § 64.1200(c)(2), 47 U.S.C. § 227(c)(5) Up to $500, or up to $1,500 if willful or knowing Not a telephone solicitation, one call in 12 months, reasonable-procedures defense

What a sponsor or site should gather once a claim arrives

  1. Put a litigation hold on the recruitment platform’s call and text logs, the dialer or AI-voice settings, and the consent record for each number involved.
  2. Pull every opt-out the number sent, how the system logged it, and the date the number was suppressed.
  3. Pull any National Do Not Call Registry scrub records and the Registry version dates the campaign used.
  4. Collect the approved scripts and audio files, plus every contract that assigned consent duties between the sponsor and its vendors or sites.
  5. Talk to a lawyer before responding to a demand letter, contacting the patient, or offering a payment to resolve it.

An approved script from the institutional review board (IRB) shows exactly what each message said, and that’s the heart of any fight over whether a call was an advertisement. The firm’s TCPA defense attorneys in California page explains how demand letters and class actions move through state and federal court.

Questions trial sponsors and research sites ask about recruitment calls

Can a research site text its own patients about a new study?

Yes, and a text sent from a list without a random or sequential number generator doesn’t trigger the § 227(b) autodialer rule. A pure study invitation isn’t telemarketing either. A prerecorded or AI-voice call is different, because it needs the patient’s prior consent. A number given for treatment may not cover a sponsor-funded study, so the cleaner course is to ask patients for research-contact permission at intake.

Does mentioning payment make a recruitment text illegal?

No, mentioning payment doesn’t by itself violate the Telephone Consumer Protection Act. It can make the message an advertisement in courts that follow the Third Circuit’s Fischbein reasoning, which raises the consent bar for prerecorded or autodialed messages to signed written consent. The Second Circuit reached the opposite result in Katz. Keeping dollar amounts out of automated first contacts avoids the fight.

Is the sponsor liable if a recruitment vendor sends the texts?

Under the FCC’s 2013 vicarious liability ruling, it can be. A sponsor that controls the campaign, approves the scripts, or accepts enrolled patients knowing how the vendor found them may face liability under federal agency principles. A vendor contract with consent warranties and indemnity won’t stop a lawsuit, but it shifts the cost and documents who was responsible.

Do the quiet-hours rules apply to study invitations?

Generally no, because the 8 a.m. to 9 p.m. limit in § 64.1200(c)(1) applies to telephone solicitations, and a pure study invitation isn’t one. A message that also pitches paid services is a different story. Many sponsors send only during those hours anyway, since a late-night text invites complaints and draws attention to the campaign.

If a study recruitment campaign leads to a TCPA claim

If your company is accused of calling or texting patients about a clinical trial without consent, the exact script and the consent record for each number usually decide the case. Rosenberger + Kawabata represents businesses defending TCPA lawsuits and class actions through its business litigation practice, including claims involving prerecorded study-recruitment calls and AI-voice prescreening. Contact Rosenberger + Kawabata online for a confidential consultation, or call (310) 894-6921.

Sources

The statute is the Telephone Consumer Protection Act at 47 U.S.C. § 227. The FCC’s rules are at 47 C.F.R. § 64.1200. The HIPAA definitions are at 45 C.F.R. § 160.103 and 45 C.F.R. § 164.501. The FCC orders are FCC 03-153 (released July 3, 2003), FCC 13-54 (released May 9, 2013), FCC 15-72 (released July 10, 2015), and FCC 24-17 (released Feb. 8, 2024). The FDA guidance is Recruiting Study Subjects.

The court decisions are Facebook, Inc. v. Duguid, 592 U.S. 395 (2021); McLaughlin Chiropractic Associates v. McKesson Corp., 606 U.S. 146 (2025); Chesbro v. Best Buy Stores, L.P., 705 F.3d 913 (9th Cir. 2012); Fischbein v. Olson Research Group, Inc., 959 F.3d 559 (3d Cir. 2020); and Bruce Katz, M.D., P.C. v. Focus Forward, LLC, 22 F.4th 368 (2d Cir. 2022).

This post is general information about the Telephone Consumer Protection Act and related laws as of February 19, 2026. It is not legal advice, and reading it does not create an attorney-client relationship. Courts and the FCC change the rules in this area often, and the outcome of any claim depends on its facts. Past results do not guarantee future outcomes.

← Back to Blog

Let’s Talk.